Clinical Trial Update: Prognostic Value of PD-L1 in NSCLC

View source ↗

Summary

This entry reports an update of a clinical trial investigating whether PD-L1 expression has prognostic value in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Fondazione Ricerca Traslazionale | Conditions: Carcinoma, Non-Small-Cell Lung | Status: UNKNOWN